# EDGAR Filing Document

**Accession Number:** 0002053025
**File Stem:** 0002053025-26-000001
**Filing Date:** 2026-2
**Character Count:** 13151
**Document Hash:** 7815082170b174da946b58c737329a82
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002053025-26-000001.hdr.sgml**: 20260212

**ACCESSION NUMBER**: 0002053025-26-000001

**CONFORMED SUBMISSION TYPE**: D/A

**PUBLIC DOCUMENT COUNT**: 1

**ITEM INFORMATION**: Rule 506(b) provides a "safer harbor" for a private offering

**ITEM INFORMATION**: Investment Company Act Section 3(c)

**ITEM INFORMATION**: Section 3(c)(7)

**FILED AS OF DATE**: 20260212

**DATE AS OF CHANGE**: 20260212

**EFFECTIVENESS DATE**: 20260212

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cinven Strategic Fund 2 (No.1) Limited Partnership
- **CENTRAL INDEX KEY:** 0002053025

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** D/A
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 021-538099
- **FILM NUMBER:** 26627559

**BUSINESS ADDRESS:**
- **STREET 1:** 21 ST. JAMES'S SQUARE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** SW1Y
- **BUSINESS PHONE:** 212-455-2952

**MAIL ADDRESS:**
- **STREET 1:** 21 ST. JAMES'S SQUARE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** SW1Y

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM D

### Notice of Exempt Offering of Securities

**Notice of Amendment** (Previous Accession Number: 0002053025-25-000001)

### 1. Issuer's Identity

**CIK (Filer ID Number):** 0002053025

**Name of Issuer:** Cinven Strategic Fund 2 (No.1) Limited Partnership

**Jurisdiction of Incorporation/Organization:** UNITED KINGDOM

**Previous Names:** None

**Year of Incorporation/Organization**

- [ ] Over Five Years Ago

- [x] Within Last Five Years (Specify Year) 2024

- [ ] Yet to Be Formed

**Entity Type**

- [ ] Corporation

- [x] Limited Partnership

- [ ] Limited Liability Company

- [ ] General Partnership

- [ ] Business Trust

- [ ] Other

### 2. Principal Place of Business and Contact Information

**Name of Issuer:** Cinven Strategic Fund 2 (No.1) Limited Partnership

**Street Address 1:** 21 ST. JAMES'S SQUARE

**City:** LONDON

**State/Province/Country:** X0

**ZIP/Postal Code:** SW1Y 4JZ

**Phone Number of Issuer:** 212-455-2952

### 3. Related Persons

| Last Name                                               | First Name          | Street Address 1                        | City          | State   | ZIP/Postal Code   | Relationship                                          | Clarification of Response                       |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Cinven Limited                                          | n/a                 | 21 St. James's Square                   | London        | X0      | SW1Y 4JZ          | [ ] Executive Officer<br>[ ] Director<br>[x] Promoter | Manager of the Issuer                           |
| Cinven Capital Management (SF2) General Partner Limited | n/a                 | 21 St. James's Square                   | London        | X0      | SW1Y 4JZ          | [ ] Executive Officer<br>[ ] Director<br>[x] Promoter | General Partner of the First GP ("GPCo")        |
| Cinven Capital Management (SF2) Limited Partnership     | n/a                 | North Suite, First Floor, Regency Court | St Peter Port | Y7      | GY1 1WW           | [ ] Executive Officer<br>[ ] Director<br>[x] Promoter | General Partner of the Issuer ("First GP")      |
| Cinven UK SF2 General Partner                           | n/a                 | 21 St. James's Square                   | London        | X0      | SW1Y 4JZ          | [ ] Executive Officer<br>[ ] Director<br>[x] Promoter | General Partner of the Issuer ("Second GP")     |
| Carrier                                                 | Babett              | 21 St. James's Square                   | London        | X0      | SW1Y 4JZ          | [ ] Executive Officer<br>[x] Director<br>[ ] Promoter | Director of the GPCo/ Director of the Second GP |
| Hess                                                    | Alexandra           | 21 St. James's Square                   | London        | X0      | SW1Y 4JZ          | [ ] Executive Officer<br>[x] Director<br>[ ] Promoter | Director of Second GP/Director of the Manager   |
| Badillos                                                | Jorge Quemada Saenz | 21 St. James's Square                   | London        | X0      | SW1Y 4JZ          | [ ] Executive Officer<br>[x] Director<br>[ ] Promoter | Director of the Manager                         |
| Schick                                                  | Bruno Otmar         | 21 St. James's Square                   | London        | X0      | SW1Y 4JZ          | [ ] Executive Officer<br>[x] Director<br>[ ] Promoter | Director of the Manager                         |
| Colato                                                  | Michael Andrew      | 112 Barrowgate Road                     | London        | X0      | W4 4QP            | [ ] Executive Officer<br>[x] Director<br>[ ] Promoter | Director of the GPCo                            |
| Crewe                                                   | Maxim Devin         | 21 St. James's Square                   | London        | X0      | SW1Y 4JZ          | [ ] Executive Officer<br>[x] Director<br>[ ] Promoter | Director of the Manager                         |
| Pettersson                                              | Sven Gosta Pontus   | 21 St. James's Square                   | London        | X0      | SW1Y 4JZ          | [ ] Executive Officer<br>[x] Director<br>[ ] Promoter | Director of the Manager                         |
| Railhac                                                 | Thomas              | 21 St. James's Square                   | London        | X0      | SW1Y 4JZ          | [ ] Executive Officer<br>[x] Director<br>[ ] Promoter | Director of the Manager                         |

### 4. Industry Group

| | | |
|:---|:---|:---|
| [ ] Agriculture | [ ] Health Care | [ ] Retailing |
| [ ] Banking & Financial Services | [ ] Biotechnology | [ ] Restaurants |
|   [ ] Commercial Banking | [ ] Health Insurance | [ ] Technology |
|   [ ] Insurance | [ ] Hospitals & Physicians |   [ ] Computers |
|   [ ] Investing | [ ] Pharmaceuticals |   [ ] Telecommunications |
|   [ ] Investment Banking | [ ] Other Health Care |   [ ] Other Technology |
|   [x] Pooled Investment Fund | [ ] Manufacturing | [ ] Travel |
|     [ ] Hedge Fund | [ ] Real Estate |   [ ] Airlines & Airports |
|     [x] Private Equity Fund |   [ ] Commercial |   [ ] Lodging & Conventions |
|     [ ] Venture Capital Fund |   [ ] Construction |   [ ] Tourism & Travel Services |
|     [ ] Other Investment Fund |   [ ] REITS & Finance |   [ ] Other Travel |
|   Is the issuer registered as an investment company? <br>  [ ] Yes [x] No |   [ ] Residential | [ ] Other |
|   [ ] Other Banking & Financial Services |   [ ] Other Real Estate |  |
| [ ] Business Services |  |  |
| [ ] Energy |  |  |
|   [ ] Coal Mining |  |  |
|   [ ] Electric Utilities |  |  |
|   [ ] Energy Conservation |  |  |
|   [ ] Environmental Services |  |  |
|   [ ] Oil & Gas |  |  |
|   [ ] Other Energy |  |  |

### 5. Issuer Size

| **Revenue Range** | **OR** | **Aggregate Net Asset Value Range** |
|:---|:---:|:---|
| [ ] No Revenues | | [ ] No Aggregate Net Asset Value |
| [ ] $1 - $1,000,000 | | [ ] $1 - $5,000,000 |
| [ ] $1,000,001 - $5,000,000 | | [ ] $5,000,001 - $25,000,000 |
| [ ] $5,000,001 - $25,000,000 | | [ ] $25,000,001 - $50,000,000 |
| [ ] $25,000,001 - $100,000,000 | | [ ] $50,000,001 - $100,000,000 |
| [ ] Over $100,000,000 | | [ ] Over $100,000,000 |
| [x] Decline to Disclose | | [ ] Decline to Disclose |
| [ ] Not Applicable | | [ ] Not Applicable |

### 6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

| | | |
|:---|:---|:---|
| [ ] Rule 504(b)(1) (not (i), (ii) or (iii)) | [x] Investment Company Act Section 3(c) |  |
| [ ] Rule 504(b)(1)(i) |   [ ] Section 3(c)(1) |  |
| [ ] Rule 504(b)(1)(ii) |   [ ] Section 3(c)(2) |   [ ] Section 3(c)(9) |
| [ ] Rule 504(b)(1)(iii) |   [ ] Section 3(c)(3) |   [ ] Section 3(c)(10) |
| [x] Rule 506(b) |   [ ] Section 3(c)(4) |   [ ] Section 3(c)(11) |
| [ ] Rule 506(c) |   [ ] Section 3(c)(5) |   [ ] Section 3(c)(12) |
| [ ] Securities Act Section 4(5) |   [ ] Section 3(c)(6) |   [ ] Section 3(c)(13) |
|  |   [x] Section 3(c)(7) |   [ ] Section 3(c)(14) |

### 7. Type of Filing

**New Notice:** [ ] **Date of First Sale:** 2025-02-26

**Amendment:** [x]

### 8. Duration of Offering

Does the issuer intend this offering to last more than one year? [x] Yes [ ] No

### 9. Type(s) of Securities Offered

- [ ] Equity
- [ ] Debt
- [ ] Option, Warrant or Other Right to Acquire Another Security
- [ ] Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
- [x] Pooled Investment Fund Interests
- [ ] Tenant-in-Common Securities
- [ ] Mineral Property Securities
- [ ] Other

### 10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? [ ] Yes [x] No

### 11. Minimum Investment
**Minimum investment accepted from any outside investor:** $0 USD

### 12. Sales Compensation

**Recipient:** — **Recipient CRD Number:** [x] None

**(Associated) Broker or Dealer:** — **(Associated) Broker or Dealer CRD Number:** [x] None

### 13. Offering and Sales Amounts

**Total Offering Amount:** USD or [x] Indefinite

**Total Amount Sold:** $1,769,842,201 USD

**Total Remaining to be Sold:** USD or [x] Indefinite

### 14. Investors

Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering: [ ] Yes [x] No

**Total Number of Investors Already Invested:** 28

### 15. Sales Commissions & Finder's Fees Expenses

Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

**Sales Commissions** $0 USD

**Finders' Fees** $0 USD

### 16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters: **$0 USD**

### Signature and Submission

Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

**Terms of Submission**

In submitting this notice, each issuer named above is:

* Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.

* Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated
officer of the State in which the issuer maintains its principal place of business and any State in which this notice is
filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any
notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any
Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to
the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in
connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or
indirectly, upon the provisions of: (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust
Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or
regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place
of business or any State in which this notice is filed.

* Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

Each issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

| Issuer                                             | Signature          | Name of Signer                   | Title                               | Date       |
|:---|:---|:---|:---|:---|
| Cinven Strategic Fund 2 (No.1) Limited Partnership | /s/ Babett Carrier | Cinven Limited by Babett Carrier | Authorized signatory of the Manager | 2026-02-12 |

*Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.*